🔎 Trials Near Me

Dachaigh › Ailseachadh nan Sgamhan › South Carolina › Charleston

Sgrùdaidhean clionaigeach Ailseachadh nan Sgamhan ann an Charleston, SC

Tha aon sgrùdadh airson Ailseachadh nan Sgamhan a’ lorg phàirtichean aig làrach ann no faisg air Charleston. Fosglaidh e gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

A’ fastadhÌre 3
  • Ralph H Johnson VA Medical Center, Charleston
  • Medical University of South Carolina, Charleston
Aoisean 70 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06096844

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

A’ fastadhÌre 3
  • Bon Secours Saint Francis Hospital, Charleston
  • Medical University of South Carolina, Charleston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT04267848

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

A’ fastadhÌre 3
  • Medical University of South Carolina-Hollings Cancer Center ( Site 0045), Charleston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06312137

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

A’ fastadhÌre 3
  • Medical University of South Carolina, Charleston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT06119581

Health Education Approach to Lung Screening

A’ fastadhFàilte do shaor-thoilich fhallain
  • Medical University of South Carolina, Charleston
Aoisean 50 gu 80 · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT06070870

Prediction Augmented Screening Initiative

A’ fastadh
  • Ralph H. Johnson VA Medical Center, Charleston, SC, Charleston
Aoisean 50 gu 80 · Gach gnè · Air ùrachadh 26 Ògmh 2026 · NCT06538636

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

A’ fastadhÌre 2
  • Ralph H Johnson VA Medical Center, Charleston
  • Medical University of South Carolina, Charleston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 3 Ògmh 2026 · NCT05642572

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

A’ fastadhÌre 2/3
  • Medical University of South Carolina, Charleston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Cèit 2026 · NCT06616584

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
  • Medical University of South Carolina, Charleston
Aoisean 40 agus nas sine · Gach gnè · Air ùrachadh 20 Faoi 2026 · NCT05366881

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

A’ fastadhSgrùdadh amharc
  • Medical University of South Carolina (MUSC), Charleston
Aoisean 50 agus nas sine · Gach gnè · Air ùrachadh 5 Lùna 2025 · NCT06122077

Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier

A’ fastadhSgrùdadh amharc
  • Ralph H. Johnson VA Health Care System, Charleston
Aoisean 29 gu 85 · Gach gnè · Air ùrachadh 13 Samh 2024 · NCT06426628

Sgrùdaidhean Ailseachadh nan Sgamhan ann am bailtean eile

Sgrùdaidhean eile ann an Charleston

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.